Life Science Investing Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
Life Science Investing Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
Life Science Investing Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
Life Science Investing Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
life science investing Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
RZOLV Technologies Announces Independent SGS Lab-Scale Test Results on Gravity Concentrates - 98.7% Gold Recoveries
